Warning: The NCBI web site requires JavaScript to function. more...
Effective use of TNF antagonists.
Yocum D.
Arthritis Res Ther. 2004;6 Suppl 2:S24-30. Epub 2004 Jun 21. Review.
Related citations
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.
The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
Finckh A, Dehler S, Gabay C; SCQM doctors.
Ann Rheum Dis. 2009 Jan;68(1):33-9. Epub 2008 Jan 29.
The comparative safety and effectiveness of TNF-alpha antagonists [corrected].
Solomon DH.
J Manag Care Pharm. 2007 Jan;13(1 Suppl):S7-18. Review. Erratum in: J Manag Care Pharm. 2007 Apr;13(3):292.
[Biologic therapy of rheumatoid arthritis].
Damjanov N, Vojinović J.
Srp Arh Celok Lek. 2009 Mar-Apr;137(3-4):205-10. Review. Serbian.
Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.
Brennan A, Bansback N, Nixon R, Madan J, Harrison M, Watson K, Symmons D.
Rheumatology (Oxford). 2007 Aug;46(8):1345-54. Epub 2007 Jun 11.
[New drugs and treatment strategies for rheumatoid arthritis].
Fantini F.
Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian.
Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept.
Laganà B, Vinciguerra M, D'Amelio R.
Clin Drug Investig. 2009;29(3):185-202. doi: 10.2165/00044011-200929030-00005. Review.
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.
Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.
Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.
Moreland LW.
Pharmacoeconomics. 2004;22(2 Suppl 1):39-53. Review. Erratum in: Pharmacoeconomics. 2004;22(8):547.
Biologics in rheumatoid arthritis.
Sharma PK, Hota D, Pandhi P.
J Assoc Physicians India. 2004 Mar;52:231-6. Review.
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
Schwartzman S, Fleischmann R, Morgan GJ Jr.
Arthritis Res Ther. 2004;6 Suppl 2:S3-S11. Epub 2004 Jun 21. Review.
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Clark W, Jobanputra P, Barton P, Burls A.
Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y, Teoh LS, Fischkoff SA, Chartash EK.
Arthritis Rheum. 2004 May;50(5):1400-11.
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
Keating GM, Perry CM.
BioDrugs. 2002;16(2):111-48. Review.
Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y.
Curr Med Res Opin. 2008 Aug;24(8):2283-94. Epub 2008 Jun 27. Review.
Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.
Wisłowska M, Jakubicz D.
Rheumatol Int. 2007 May;27(7):641-7. Epub 2007 Jan 18.
Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
[No authors listed]
Prescrire Int. 2010 Feb;19(105):30-4. Review.
Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.
Doan QV, Chiou CF, Dubois RW.
J Manag Care Pharm. 2006 Sep;12(7):555-69. Review.
Can remission be maintained with or without further drug therapy in rheumatoid arthritis?
Saleem B, Nizam S, Emery P.
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-33-6. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on